Title: Transforming the treatment of schizophrenia: Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disorders

Funder
University of Sussex,Wellcome Trust

Principal Investigator

Co-Investigators
Atack, John

Project Details
Net value award figure for Cardiff University: £3,466,448.00
Start date: 01/08/2017
End date: 30/03/2021

Last updated on 2020-08-08 at 06:02